Showing results (401-410 of 424) with videos related to

Sort By:
Pageof 43
Oncoimmunology|June 29, 2026
Efficacy and safety of cabozantinib plus nivolumab in advanced non-clear cell renal cell carcinoma: a nationwide multicenter studyChang Gon Kim, Junkyu Kim, In-Ho Kim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 13, 2009
Prognostic factors and clinical outcomes of high-dose chemotherapy followed by autologous stem cell transplantation in patients with peripheral T cell lymphoma, unspecified: complete remission at transplantation and the prognostic index of peripheral T cell lymphoma are the major factors predictive of outcomeDeok-Hwan Yang, Won Seog Kim, Seok Jin Kim, et al.
International Journal of Hematology|February 3, 2011
Clinical features of severe acquired ADAMTS13 deficiency in thrombotic thrombocytopenic purpura: the Korean TTP registry experienceMoon Ju Jang, So Young Chong, In-Ho Kim, et al.
Acta Haematologica|June 13, 2015
Azacitidine Pre-Treatment Followed by Reduced-Intensity Stem Cell Transplantation in Patients with Higher-Risk Myelodysplastic SyndromeJae-Sook Ahn, Yeo-Kyeoung Kim, Yoo Hong Min, et al.
Poultry Science|September 29, 2023
Effect of dietary supplementation of betaine and organic minerals on growth performance, serum biochemical parameters, nutrients digestibility, and growth-related genes in broilers under heat stressAhmed A Saleh, Hossam M El-Tahan, Mohammed Shaban, et al.
Cancer Research and Treatment|December 11, 2025
Zolbetuximab Plus Chemotherapy as First-Line Treatment in Patients with Claudin 18.2-Positive, HER2-Negative, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma: Korean Population Subgroup-Combined Efficacy and Safety Analysis from SPOTLIGHT and GLOWKeun-Wook Lee, Sang Cheul Oh, Jong Gwang Kim, et al.
NPJ Digital Medicine|May 19, 2025
Deep Gaussian process with uncertainty estimation for microsatellite instability and immunotherapy response prediction from histologySunho Park, Morgan F Pettigrew, Yoon Jin Cha, et al.
The Lancet. Oncology|October 16, 2022
Bemarituzumab in patients with FGFR2b-selected gastric or gastro-oesophageal junction adenocarcinoma (FIGHT): a randomised, double-blind, placebo-controlled, phase 2 studyZev A Wainberg, Peter C Enzinger, Yoon-Koo Kang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2026
EP4 Antagonist ONO-4578 Plus Nivolumab and Chemotherapy in HER2-Negative Unresectable Advanced or Recurrent Gastric or Gastroesophageal Junction CancerIzuma Nakayama, Min-Hee Ryu, Sung Hee Lim, et al.
Cancer Research and Treatment|October 14, 2025
Real World Efficacy of 1st-Line Nivolumab Plus Ipilimumab and its Practical Predictive Biomarkers in Advanced Renal Cell Carcinoma: First Analysis from RENOIR Study (KCSG GU22-13)Jwa Hoon Kim, Sang Joon Shin, Woo Kyun Bae, et al.
Pageof 43